SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Anthropic’s $2 trillion AI dream is built on a series of contradictions

Nvidia’s $500 billion AI financing plan gets a Wall Street reality check

Creative AI needs to know what not to change

Nikesh Arora’s $10 million bet keeps paying off as Palo Alto Networks crosses $330 billion

Buzz

Most popular

Daily

Weekly

1

Nikesh Arora’s $10 million bet keeps paying off as Palo Alto Networks crosses $330 billion

2

SentinelOne AI researcher uses GPT-6 Astra to crack Napoleon cipher after 217 years

3

Palo Alto Networks becomes first company to hit NIS 1 trillion on Tel Aviv Stock Exchange

4

Snyk laid off 20% of its workforce after writing off technology from Israeli acquisitions Helios and Enso

5

Nebius acquires 10-month-old stealth AI startup Inferize in $100-150 million deal

Oncology

6 stories about Oncology

Sai Jasti, senior VP and head of data science and AI at Bayer; Ofer Sharon, MD, physician and CEO of OncoHost

“Younger people are getting cancer more and more. We have to make kinder medicines.”

14.12.25|Zachy Hennessey

As AI hype accelerates, oncology’s real progress is happening quietly, driven by data, regulation, and the slow work of making cancer treatment more precise and sustainable

Protai Founders

Protai adds $12 million to Seed round as it aims to build oncology drug discovery pipeline

The Israeli startup, which has built a proteomics AI-based platform that comprehensively maps the course of a disease on the protein level, aims to better predict which patients will respond to a given drug as well as discover novel drug targets that were missed by genomic approaches

Nucleai raises $33 million for spatial biology drug development platform

22.03.22|Meir Orbach

The technology developed at the Israeli startup allows better prediction of the patient's response to specific oncological treatment, saves on the ongoing process of testing different drugs and improves the chances of the development of new cancer drugs

אוהד ארזי מנכ"ל זברה מדיקל

Israel’s Zebra Medical Vision gets its first FDA clearance in oncology

28.07.20|James Spiro

The new approval marks the sixth time the medical imaging company has earned FDA clearance

Oncology Company Alpha Tau Raises $29 Million

06.09.18|Hezi Sternlicht

Alpha Tau’s cancer treatment technology uses alpha radiation to treat solid tumors with radiation particles that are released inside the tumor, killing the surrounding cells

סרטן ריאות גידול סרטני

Israeli Oncology Company Alpha Tau is Raising Funds

22.08.18|Hezi Sternlicht

Alpha Tau is in the last stages of raising an investment of several tens of millions of dollars